GSK

MKT CAP:$99B

GlaxoSmithKline PLC ADR

Market Cap

$99B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NYSE

Healthcare·Drug Mfg.·🇺🇸·NYSE

Stock Price

$50.64+$1.85 (+3.80%)

Jun 8, 2026

52W High $60.1452W Low $34.89

Company Details

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationall...

CEO

—

IPO Date

Jul 9, 1986

Website

www.gsk.com

Key Metrics TTM (GBP)

Revenue

£32.8B

+4.0% YoY

Net Income

£5.8B

EPS (Diluted)

Free Cash Flow

£6.2B

Revenue / Share

£16.09

Gross Margin

72.7%

Operating Margin

25.7%

Net Margin

17.8%

FCF Margin

19.0%

P/S

P/E

Earnings Reports

Q2 2026

Jul 28, 2026

PENDING

Q1 2026

Apr 29, 2026

£7.6B+1.5%

FY 2025

Mar 6, 2026

£32.7B+4.1%

Q4 2025

Mar 6, 2026

£8.6B+6.2%

Q3 2025

Oct 28, 2025

£8.5B+6.7%

Revenue & Profitability (GBP)

Operating Cash Flow (GBP)

CapEx Spend (GBP)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (GBP)

OpEx Breakdown (GBP)

War Chest (GBP)

Shares Outstanding

Revenue Per Employee (GBP)

Revenue / Employee